These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37693476)

  • 1. Protein Coronas on Functionalized Nanoparticles Enable Quantitative and Precise Large-Scale Deep Plasma Proteomics.
    Huang T; Wang J; Stukalov A; Donovan MKR; Ferdosi S; Williamson L; Just S; Castro G; Cantrell LS; Elgierari E; Benz RW; Huang Y; Motamedchaboki K; Hakimi A; Arrey T; Damoc E; Kreimer S; Farokhzad OC; Batzoglou S; Siddiqui A; Van Eyk JE; Hornburg D
    bioRxiv; 2023 Aug; ():. PubMed ID: 37693476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano-bio interactions.
    Ferdosi S; Tangeysh B; Brown TR; Everley PA; Figa M; McLean M; Elgierari EM; Zhao X; Garcia VJ; Wang T; Chang MEK; Riedesel K; Chu J; Mahoney M; Xia H; O'Brien ES; Stolarczyk C; Harris D; Platt TL; Ma P; Goldberg M; Langer R; Flory MR; Benz R; Tao W; Cuevas JC; Batzoglou S; Blume JE; Siddiqui A; Hornburg D; Farokhzad OC
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2106053119. PubMed ID: 35275789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Competition at the Nano-Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes.
    Ferdosi S; Stukalov A; Hasan M; Tangeysh B; Brown TR; Wang T; Elgierari EM; Zhao X; Huang Y; Alavi A; Lee-McMullen B; Chu J; Figa M; Tao W; Wang J; Goldberg M; O'Brien ES; Xia H; Stolarczyk C; Weissleder R; Farias V; Batzoglou S; Siddiqui A; Farokhzad OC; Hornburg D
    Adv Mater; 2022 Nov; 34(44):e2206008. PubMed ID: 35986672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas.
    Wang J; Xie W; Sun L; Li J; Wu S; Li R; Zhao Y
    Anal Chim Acta; 2023 Sep; 1275():341569. PubMed ID: 37524462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in high-throughput proteomic analysis].
    Wu Q; Sui X; Tian R
    Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An IonStar Experimental Strategy for MS1 Ion Current-Based Quantification Using Ultrahigh-Field Orbitrap: Reproducible, In-Depth, and Accurate Protein Measurement in Large Cohorts.
    Shen X; Shen S; Li J; Hu Q; Nie L; Tu C; Wang X; Orsburn B; Wang J; Qu J
    J Proteome Res; 2017 Jul; 16(7):2445-2456. PubMed ID: 28412812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona.
    Blume JE; Manning WC; Troiano G; Hornburg D; Figa M; Hesterberg L; Platt TL; Zhao X; Cuaresma RA; Everley PA; Ko M; Liou H; Mahoney M; Ferdosi S; Elgierari EM; Stolarczyk C; Tangeysh B; Xia H; Benz R; Siddiqui A; Carr SA; Ma P; Langer R; Farias V; Farokhzad OC
    Nat Commun; 2020 Jul; 11(1):3662. PubMed ID: 32699280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-High-Resolution IonStar Strategy Enhancing Accuracy and Precision of MS1-Based Proteomics and an Extensive Comparison with State-of-the-Art SWATH-MS in Large-Cohort Quantification.
    Wang X; Jin L; Hu C; Shen S; Qian S; Ma M; Zhu X; Li F; Wang J; Tian Y; Qu J
    Anal Chem; 2021 Mar; 93(11):4884-4893. PubMed ID: 33687211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of automated sample preparation and micro-flow LC-MS for high-throughput plasma proteomics.
    Ye X; Cui X; Zhang L; Wu Q; Sui X; He A; Zhang X; Xu R; Tian R
    Clin Proteomics; 2023 Jan; 20(1):3. PubMed ID: 36611134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics.
    Brusniak MY; Bodenmiller B; Campbell D; Cooke K; Eddes J; Garbutt A; Lau H; Letarte S; Mueller LN; Sharma V; Vitek O; Zhang N; Aebersold R; Watts JD
    BMC Bioinformatics; 2008 Dec; 9():542. PubMed ID: 19087345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput, in-depth and estimated absolute quantification of plasma proteome using data-independent acquisition/mass spectrometry ("HIAP-DIA").
    Zhou Y; Tan Z; Xue P; Wang Y; Li X; Guan F
    Proteomics; 2021 Mar; 21(5):e2000264. PubMed ID: 33460299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking quantitative label-free LC-MS data processing workflows using a complex spiked proteomic standard dataset.
    Ramus C; Hovasse A; Marcellin M; Hesse AM; Mouton-Barbosa E; Bouyssié D; Vaca S; Carapito C; Chaoui K; Bruley C; Garin J; Cianférani S; Ferro M; Van Dorssaeler A; Burlet-Schiltz O; Schaeffer C; Couté Y; Gonzalez de Peredo A
    J Proteomics; 2016 Jan; 132():51-62. PubMed ID: 26585461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
    Gritsenko MA; Xu Z; Liu T; Smith RD
    Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.
    Keshishian H; Burgess MW; Specht H; Wallace L; Clauser KR; Gillette MA; Carr SA
    Nat Protoc; 2017 Aug; 12(8):1683-1701. PubMed ID: 28749931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized Workflow for Precise Mid- and High-Throughput Proteomics of Blood Biofluids.
    Mc Ardle A; Binek A; Moradian A; Chazarin Orgel B; Rivas A; Washington KE; Phebus C; Manalo DM; Go J; Venkatraman V; Coutelin Johnson CW; Fu Q; Cheng S; Raedschelders K; Fert-Bober J; Pennington SR; Murray CI; Van Eyk JE
    Clin Chem; 2022 Mar; 68(3):450-460. PubMed ID: 34687543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Quality Control Procedures for Large-Scale Plasma Proteomics Analyses.
    Patterson KL; Arul AB; Choi MJ; Oliver NC; Whitaker MD; Bodrick AC; Libby JB; Hansen S; Dumitrescu L; Gifford KA; Jefferson AL; Hohman TJ; Robinson RAS
    J Am Soc Mass Spectrom; 2023 Jun; 34(6):1105-1116. PubMed ID: 37163770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.